AlphaRx Inc. Receives SFDA Approval for Topical Arthritis Product

December 7, 2007, -- AlphaRx (OTCBB:ALRX) received approval from the State FDA of China for Indaflex™, a topical arthritis relief product. Indaflex™ is a topical formulation of Indomethacin that is incorporated in a nanotechnology drug delivery system developed by AlphaRx. Previously, Indaflex™ was approved in Mexico. AlphaRx International Holdings (AIH), the Hong Kong affiliate of AlphaRx, will launch Indaflex™ in 2008, and it is already building a plant in China to produce the drug. More details....